This report contains market size and forecasts of Venous Thromboembolism Therapeutics Drugs in global, including the following market information:
Global Venous Thromboembolism Therapeutics Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Venous Thromboembolism Therapeutics Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Venous Thromboembolism Therapeutics Drugs companies in 2021 (%)
The global Venous Thromboembolism Therapeutics Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Heparin Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Venous Thromboembolism Therapeutics Drugs include Bayer, BMS, Boehringer Ingelheim, Daiichi Sankyo, Johnson & Johnson, Sanofi, Altor Bioscience, Armetheon and Aspen Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Venous Thromboembolism Therapeutics Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Venous Thromboembolism Therapeutics Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Venous Thromboembolism Therapeutics Drugs Market Segment Percentages, by Type, 2021 (%)
Heparin
Apixaban
Dabigatran
Rivaroxaban
Edaxaban
Warfarin
Global Venous Thromboembolism Therapeutics Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Venous Thromboembolism Therapeutics Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Global Venous Thromboembolism Therapeutics Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Venous Thromboembolism Therapeutics Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Venous Thromboembolism Therapeutics Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Venous Thromboembolism Therapeutics Drugs revenues share in global market, 2021 (%)
Key companies Venous Thromboembolism Therapeutics Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Venous Thromboembolism Therapeutics Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
BMS
Boehringer Ingelheim
Daiichi Sankyo
Johnson & Johnson
Sanofi
Altor Bioscience
Armetheon
Aspen Pharma
BioInvent
eXIthera Pharmaceuticals
Gamma Therapeutics